Clinical Trials on Protein Kinase Inhibitors in United States
Total 3111 results
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Celgene CorporationCompletedAllogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete RemissionMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterSmithKline BeechamCompleted
-
Vivolux ABTheradexTerminated
-
Beth Israel Deaconess Medical CenterTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
Cristina GasparettoCelgeneActive, not recruiting
-
Wake Forest University Health SciencesBristol-Myers Squibb; Atrium Health Levine Cancer InstituteActive, not recruitingMultiple MyelomaUnited States
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital; GlycoMimetics IncorporatedCompleted
-
Duke UniversityGlaxoSmithKlineCompletedMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Wake Forest University Health SciencesJanssen Research & Development, LLCWithdrawnMultiple MyelomaUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
University of California, San FranciscoCompletedMultiple MyelomaUnited States
-
Washington University School of MedicineAlliance for Clinical Trials in OncologyTerminated
-
Acrotech Biopharma Inc.CompletedMultiple MyelomaUnited States
-
Washington University School of MedicineTerminated
-
Medical University of South CarolinaGenentech, Inc.CompletedMultiple MyelomaUnited States
-
University of ArkansasNational Institutes of Health (NIH)CompletedMultiple MyelomaUnited States
-
OncotherapeuticsMillennium Pharmaceuticals, Inc.TerminatedMultiple MyelomaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
Washington University School of MedicineCompleted
-
University of ArkansasOnyx Therapeutics, Inc.No longer available
-
University of ArkansasCompleted
-
Duke UniversityCephalonTerminatedMultiple MyelomaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States
-
Enzon Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
University of ArkansasCompletedMultiple MyelomaUnited States
-
University of ArkansasCompleted
-
Cangene CorporationWithdrawnHemophilia BUnited Kingdom, United States
-
St. Jude Children's Research HospitalNot yet recruiting
-
Shayna Sarosiek, MDADC Therapeutics S.A.Recruiting
-
Masonic Cancer Center, University of MinnesotaCompletedLymphoma | Multiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityTerminatedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterDaiichi Sankyo UK Ltd.Terminated
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...MedImmune LLCCompleted
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Mayo ClinicrEVO BiologicsTerminatedThrombophilia Due to Acquired Antithrombin III DeficiencyUnited States
-
Emory UniversityMillennium Pharmaceuticals, Inc.Terminated
-
M.D. Anderson Cancer CenterAnorMEDCompleted
-
Montefiore Medical CenterGenentech, Inc.Not yet recruitingHemophilia AUnited States
-
Emory UniversityOctapharmaRecruitingHemophilia AUnited States, Germany